NOSOTROS:
Pfizer: One of the world's premier biopharmaceutical companies Sorry, you need to enable JavaScript to visit this website. Skip to main content Header Top MenuCareersInvestorsNews Press Release ArchivePress StatementsPodcastsThe Antigen PodcastGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitTTR-Amyloidosis Press KitUC NarrativePartners Discovery to Pre-candidateFocus AreasTherapeutic AreasInternal MedicineInflammation and ImmunologyOncologyRare DiseaseVaccinesTherapeutic Modalities and Technology PlatformsDrug SafetyGene TherapyTarget SciencesPrecision MedicineMedicinal SciencesBiologics Product & Process DevelopmentBiotherapeutics DiscoveryMedicine DesignSmall Molecule Product & Process DevelopmentEmerging ScienceDNA Damage ResponseMicrosatellite Repeat ExpansionsTissue Resident ImmunityPartnering ModelsCandidate Through CommercializationFocus AreasInternal MedicineInflammation and ImmunologyOncologyRare DiseaseVaccinesHospitalPfizer CentreOnePfizer VenturesOur portfolioHealthcare ProfessionalsHealthcare ProfessionalsConnect with UsConnect with Us EmailFAQPrivacy Policy (NEW)YouTubeTwitterFacebookLinkedInInstagram ApplyToggle navigation Your HealthHealthy Living Brain & Nervous System Cardiovascular HealthCold & FluDigestive HealthHealthier AgingLiving Tobacco Free Men’s HealthMental HealthNutrition & FitnessPediatric HealthRespiratory HealthSkin HealthVaccines & PreventionWomen’s HealthDisease & Condition CancerCardiovascular Diseases & ConditionsDiabetes & Metabolic DisordersImmune System Diseases & ConditionsInfections & Infectious DiseasesNeurological Diseases & ConditionsMenopauseRare DiseaseVaccine-Related ConditionsSkin Diseases & ConditionsCoronavirus disease (COVID-19)Managing your health CaregivingEvaluating Health InformationTracking Your HealthYour MedicinesHealth LiteracyWellnessHot TopicsMaintaining Emotional Well-Being During COVID-19Our ScienceDriven to Discover the cureFocus Areas Internal MedicineInflammation & ImmunologyOncologyRare DiseaseVaccinesAnti InfectivesProduct PipelineClinical Trials Guide to Clinical TrialsFind a TrialExpanded Access & Compassionate UseClinical Trials in ChildrenPartnering with PfizerTrial Data & ResultsResearch Integrity & TransparencyDiversity in Clinical TrialsR&D Platforms BiosimilarsGene TherapyMedicinal SciencesPrecision MedicineMaternal ImmunizationCollaboration Partner with PfizerResearch sitesCoronavirus disease (COVID-19) Scientific ResourcesHOT TOPICSMRNA VS. CONVENTIONAL VACCINESOur PeopleMeet The Experts ScientistsInternal Medicine – Metabolic DiseaseInflammation & ImmunologyOncologyRare DiseaseVaccinesMedical ProfessionalsThe JourneyLeadership ExecutivesBoard MembersCompany Fact SheetDiverse Perspectives Diversity & InclusionSupplier DiversityHOT TOPICSMeet our new Chief Patient Officer, Dr. Dara Richardson-HeronWorking Together to Empower WomenHot TopicsOur PurposeCommitment to Global Health Expanding AccessStrengthening Health SystemsProviding Disaster & Humanitarian ReliefUnleashing the Power of Our ColleaguesHighlighting Individual VoicesProtecting People and the Environment Pfizer's Green JourneyProduct StewardshipEHS GovernanceEHS Supply ChainKey Performance IndicatorsHealth & SafetyHuman RightsPositions on Health Policies Ready for CuresHow does Pfizer price medicines?Value of MedicinesPolicy PositionsCreating Cures Through Facility InvestmentsTransparency Working with Health Care ProfessionalsTransparency in GrantsCode of ConductCorporate ComplianceSales and Marketing ComplianceIndependent Grants Competitive Grants ProgramIndependent Medical EducationInvestigator Sponsored ResearchQuality ImprovementContributions & Partnerships Healthcare Charitable ContributionsLobbying & Political ContributionsHOT TOPICSPfizer Women’s Resource GroupHot TopicsOur ProductsProduct listingHow drugs are made Branded vs. GenericBiologics & BiosimilarsCommitment to QualityUpjohn About UpjohnPortfolio of BrandsManufacturing PlantsUpJohn LeadershipDistributors Pfizer DistributorsGreenstone DistributorsMedicine Safety Reporting Adverse EventsMaking Good Treatment ChoicesPartnering With PatientsHealth LiteracyMedicine Safety Tips for PatientsCounterfeitingUnused MedicinesSafety Data SheetsMedical Information ContactsPfizer Global SupplyHOT TOPICSUniversal vs. Single Payer HealthcareHot TopicsCareersWorking Here Mission & PurposeCultureDiversity & InclusionCareer Growth & Colleague DevelopmentCompensation & BenefitsEnsuring Corporate ResponsibilitySearch JobsStudent & Early Career Postdoctoral ProgramUS Summer Student Worker ProgramOpportunities for VeteransPfizer365.comOur Hiring & Recruiting Process Frequently Asked QuestionsTips for Interviewing at PfizerConnect With UsInvestorsInvestors Overview Why Invest / Our StoryProspective InvestorsFact SheetEvents & PresentationsFinancials Quarterly ReportsAnnual ReportsSEC FilingsInteractive Data FilingsInvestor NewsStock Information Historical Price LookupInvestment CalculatorHistorical Stock Chart & DataDividend & Split HistoryStock FAQsGovernance Board Committees and ChartersThe Pfizer Board PoliciesCorporate Governance FAQsContact Our DirectorsShareholder Services Stock FAQsAdvisory InformationCost Basis CalculatorNewsContact Media RelationsPodcastsPress Kits & DownloadsPress Release ArchivePress StatementsPartnersFooter linksFooter Aside Section1 CAREER-SEEKERSINVESTORSNews & Media PartnersFooter Aside Section 2 Healthcare ProfessionalsBusiness To BusinessChange RegionSitemapFooter Aside Section3 TwitterFacebookLinkedinInstagramYoutubeFooter Aside Section4 Contact UsTerms of UsePrivacy Policy Our Science Our Science Greater Clarity on COVID-19 Timelines
An Open Letter from Pfizer Chairman and CEO Albert Bourla Read the LetterMoving at the Speed of ScienceOur ScienceMoving at the Speed of Science
An open letter from our Chairman and CEO on working together to build trust in science.READ THE LETTERCOVID-19 INFORMATION AND RESOURCESYour HealthCOVID-19 INFORMATION AND RESOURCES
Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.Learn MoreCOVID-19 Vaccine DevelopmentOur ScienceCOVID-19 Vaccine Development
Rapid progress on the path to develop, test and manufacture a vaccine.Learn moreSTEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSISYour HealthSTEPS FOR MANAGING FINANCES AND HEALTH INSURANCE AFTER A CANCER DIAGNOSIS
Cost should never be a barrier to receiving cancer treatment, yet there are people who forgo treatment so as not to burden their family with high medical costs.LEARN HOW TO MINIMIZE THIS BURDENSearch productsSubmit
Search products, A–Z
Need help paying for Pfizer medicines?Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.Condition, Keyword, or NCT NumberLocation SearchAdvanced SearchTHE ANTIGEN: #COVID19 PODCASTPodcastsTHE ANTIGEN: #COVID19 PODCAST
Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.Listen & subscribe hereMaintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to OsteoarthritisYour HealthMaintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis
In recognition of Pain Awareness Month, Ann and her daughter Elizabeth (Lizzie) Sullivan sat down with Grace Whiting, President & CEO of the National Alliance for Caregiving, to discuss the impact that chronic pain due to OA can have.Learn MoreLatest NewsData From Pfizer’s Adult and Pediatric Clinical…
Investigational vaccine demonstrated positive safety results and immune responses to 20 S. pneumoniae serotypes in adults and infants Pfizer has submitted to the FDA its biologics license application for adults 18 years of age or older and awaits acceptance for review Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults… Read more Footer menuYour Health Healthy LivingDisease ConditionsManage Your HealthOur Science Therapeutic AreasProduct PipelineClinical TrialsR&D PlatformsCollaborationResearch SItesOur People Meet the ExpertsThe JourneyLeadershipDiverse PerspectivesOur Purpose Commitment To Global HealthPositions on Health PoliciesTransparencyContributions & PartnershipsOur Products Product ListingHow Drugs are MadeDistributorsGlobal Product Information ContactsFooter asideFooter Aside Section1 CAREER-SEEKERSINVESTORSNews & Media PartnersFooter Aside Section 2 Healthcare ProfessionalsBusiness To BusinessChange RegionSitemapFooter Aside Section3 TwitterFacebookLinkedinInstagramYoutubeFooter Aside Section4 Contact UsTerms of UsePrivacy Policy
Copyright © 2002-2020 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.
